Please Wait
Applying Filters...
menu
    • menu
    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Tagoor Lab Vildagliptin

    Virtual Booth

    Contact Supplier

    Vildagliptin

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Gentec Pharmaceutical Group is focused on manufacturing & developing APIs/HPAPIs, Advanced Intermediates & Fine Chemicals.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-03-17

    Virtual Booth

    Contact Supplier

    Menu

    Vildagliptin

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 488Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Acquired approval for manufacture & marketing generic drugs
    Acquired approval for manufacture & marketing generic drugs

    17 Feb 2025

    // PRESS RELEASE

    https://www.towayakuhin.co.jp/english/assets/release250217.pdf

    PRESS RELEASE
    17 Feb 2025
    Share Share
    Listing of New Products New Generics In NHI Drug Price Standard
    Listing of New Products New Generics In NHI Drug Price Standard

    05 Nov 2024

    // PRESS RELEASE

    https://www.towayakuhin.co.jp/english/assets/release241205.pdf

    PRESS RELEASE
    05 Nov 2024
    Share Share
    Acquired approval for manufacturing and marketing generic drugs
    Acquired approval for manufacturing and marketing generic drugs

    15 Aug 2024

    // PRESS RELEASE

    https://www.towayakuhin.co.jp/english/assets/release240815.pdf

    PRESS RELEASE
    15 Aug 2024
    Share Share
    Tiefenbacher Successfully Launches Generic Version Diabetis Med Vildagliptin
    Tiefenbacher Successfully Launches Generic Version Diabetis Med Vildagliptin

    08 Sep 2022

    // PRESS RELEASE

    https://tiefenbachergroup.com/2022/09/08/new-market-launch-tiefenbacher-pharmaceuticals-successfully-launches-generic-version-of-the-diabetis-medicine-vildagliptin-and-vildagliptin-metformin-in-africa/

    PRESS RELEASE
    08 Sep 2022
    Share Share
    Accord Healthcare Vildagliptin/Metformin HCL Receives Approval in Europe
    Accord Healthcare Vildagliptin/Metformin HCL Receives Approval in Europe

    17 Jun 2022

    // EMA

    https://www.ema.europa.eu/en/documents/overview/vildagliptin/metformin-hydrochloride-accord-epar-medicine-overview_en.pdf

    EMA
    17 Jun 2022
    Share Share
    Glenmark Pharma launches FDC drug for type 2 diabetes
    Glenmark Pharma launches FDC drug for type 2 diabetes

    26 Oct 2021

    // PHARMABIZ

    http://www.pharmabiz.com/NewsDetails.aspx?aid=143498&sid=2

    PHARMABIZ
    26 Oct 2021
    Share Share